Medical Device News Magazine

Signia Announces New HandsFree Phone Call Feature for its Augmented Xperience Hearing Aids

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Augmented Xperience: Furthering its mission to enhance human performance, hearing aid innovator Signia today announced that its breakthrough Augmented Xperience (AX) hearing aid platform will now support hands-free phone calls. The HandsFree feature upgrade will be available Spring 2022 for all new and existing AX hearing aids paired with iOS devices.

By utilizing the HandsFree feature, consumers with select iOS devices will be able to hold conversations through their Signia AX hearing aids without having to speak directly into their phone or tablet. Instead, the hearing aids’ microphones will pick up the wearer’s voice and transmit it to the conversation partner at the other end of the line via Bluetooth®.

“With the HandsFree upgrade, wearers can keep their phone comfortably stowed in their pocket, purse, or even across the room whenever they take a call,” stated Mike O’Neil, President of Signia USA. “The HandsFree feature further underscores our commitment to enhancing human performance through optimized hearing – even when the conversation isn’t taking place in-person.”

This new upgrade marks the latest in Signia’s ongoing commitment to providing consumers with the effortless streaming and connectivity they require to enhance their performance – whether that be in in-person or on the phone.

Leveraging the benefits of Signia AX technology for hands-free phone calls

Through the Augmented Xperience platform, wearers benefit from outstanding speech clarity when taking hands-free calls at home, in the office, or on a busy street. Rather than simply amplifying all sounds, the AX platform intelligently understands which sounds should be pulled to the foreground and prioritized, and which sounds should remain in the background.

Rooted in the first-of-its-kind Augmented Focus™ technology – which leverages two independent processors to address speech and background noise separately – speech becomes closer to the wearer while surrounding sounds stay in the background.

Studies have shown that Signia AX results in greater than 25 percent better speech understanding in noise compared to users’ own hearing aids. Additionally, 95% of study participants reported excellent speech understanding in their home environment.[1]

Signia AX has proven to change how wearers hear the world in quiet, moderate and noisy environments. By elevating the listening experience in all surroundings, wearers can enjoy a fully immersive soundscape anywhere they take a hands-free phone call.

“The HandsFree feature is one of several additional innovative features in the pipeline for the AX platform,” added O’Neil. “When hearing care professionals fit a patient with Signia AX hearing aids, they can be confident that they’re giving patients not only an exceptional solution today, but also one that’s future-proofed for tomorrow.”

The HandsFree feature will be available in all new and existing Signia AX hearing aids through an update in Spring 2022.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”